Greg Roche

CEO | Distalmotion

Greg Roche joined Distalmotion in December 2023 as CEO with more than 20 years of commercial and executive experience in the Medtech industry, bringing a wealth of expertise across laparoscopic surgery, endoscopic visualization, and surgical robotics.

Most recently, Roche served as CEO of Avateramedical, adding to his leadership and experience within soft-tissue robotic technologies. Prior to this, he was Global President, Robotics and Technology at Zimmer Biomet, where he led the successful global launch of the ROSA® Robotic Knee System and delivered above market growth for the company, in part by developing innovative business models tailored to meet the unique demands of the Ambulatory Surgical Centers (ASC’s). Beginning in the early 2000’s, Roche served in multiple US commercial and leadership roles across Stryker.

All Sessions by Greg Roche

  • May 1, 2024

    Wednesday

  • 1:45 PM  - 2:30 PM
    Distalmotion is a medical device company founded in Lausanne, Switzerland with a mission to empower robotic surgery to more hospitals, surgeons, and patients worldwide. Distalmotion is commercial with multiple installations across France, Germany, and Switzerland. Its surgical robot Dexter® is designed to offer Simplicity, Accessibility and Excellence. It delivers the benefits of robotics to more hospitals by being simple and straightforward to use, and more accessible as a modular, small format, and open system. As an open system, Dexter is designed to work natively with third party 3D imaging systems, energy devices, vessel sealers and other laparoscopic devices. It has a suite of fully wristed single use instruments providing the user with dexterity, precision of movement, reliable instrument performance, and lower reprocessing requirements.
    Bringing Products to Market
    Where
    159




Share

Greg Roche